Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:11 PM
Ignite Modification Date:
2025-12-24 @ 2:11 PM
NCT ID:
NCT05634395
Eligibility Criteria:
Inclusion Criteria:
* Women over 70 years of age,
* With histologically confirmed invasive breast cancer,
* Regardless of histological subtype (hormone receptor positive (HR+), negative (HR-), with or without HER2 overexpression, or triple negative)
* Treated with local (surgery, radiotherapy) or systemic (hormone therapy, monotherapy, anti HER2, chemotherapy: patient is eligible for inclusion up to one month after initial diagnosis or recurrence (local or distant) of breast cancer,
* PS ≤ 2,
* Willing and available to invest in the project for the duration of the study,
* Using a personal smartphone or personal tablet compatible with the "Withings Health Mate" app (iOS 10/android 5.0 and later) and with an internet connection,
* Affiliated with a social security plan,
* Having dated and signed an informed consent,
* Able to read, write and understand French.
Exclusion Criteria:
* Presence of disabling metastases,
* Moderate to severe cognitive impairment,
* Persons deprived of liberty or under guardianship,
* Inability to undergo the medical follow-up of the trial for geographical, social or psychological reasons,
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
70 Years
Study:
NCT05634395
Study Brief:
Protocol Section:
NCT05634395